Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay
The assay demonstrated robust performance in identifying a core group of patients with high-risk ER+/HER2- breast cancer for whom additional adjuvant treatment may be futile.
Authors
- Fabrice André (ORCID: https://orcid.org/0000-0001-5795-8357)
- François‐Clément Bidard (ORCID: https://orcid.org/0000-0001-5932-8949)
- Barbara Pistilli (ORCID: https://orcid.org/0000-0002-9184-7199)
- Magali Lacroix‐Triki (ORCID: https://orcid.org/0000-0002-6641-8536)
- Anne‐Laure Martin (ORCID: https://orcid.org/0000-0002-9302-8576)
- Thomas Walter (ORCID: https://orcid.org/0000-0001-7419-7879)
- Cécile Badoual (ORCID: https://orcid.org/0000-0002-1143-3085)
- Antonio Di Meglio (ORCID: https://orcid.org/0000-0002-0233-3189)
- Grégoire Gessain (ORCID: https://orcid.org/0000-0001-6800-0339)
- Anne Vincent‐Salomon (ORCID: https://orcid.org/0000-0001-5754-5771)
- Mariana Chávez‐MacGregor (ORCID: https://orcid.org/0000-0002-7189-0763)
- Thomas Bachelot (ORCID: https://orcid.org/0000-0002-0866-9484)
- Antoine Bichat (ORCID: https://orcid.org/0000-0001-6599-7081)
- Frédérique Penault‐Llorca (ORCID: https://orcid.org/0000-0002-4279-5492)
- Marvin Lerousseau (ORCID: https://orcid.org/0000-0001-6421-708X)
- Jérôme Lemonnier (ORCID: https://orcid.org/0000-0002-8821-2168)
- Damien Drubay (ORCID: https://orcid.org/0000-0002-9997-9727)
- Sylvain Berlemont
- Farah Sassi (ORCID: https://orcid.org/0000-0003-2078-6795)
- Hope S. Rugo (ORCID: https://orcid.org/0000-0001-6710-4814)
- Joana Ribeiro (ORCID: https://orcid.org/0000-0001-7947-672X)
- Inês Vaz-Luís (ORCID: https://orcid.org/0000-0002-7194-2260)
- Catherine Gaudin
- Lucie Frechin
Institutions
- nLIGHT (United States) (US)
- The University of Texas MD Anderson Cancer Center (US)
- Inserm (FR)
- Université Paris Sciences et Lettres (FR)
- Institut Gustave Roussy (FR)
- Centre Léon Bérard (FR)
- City of Hope (US)
- Centre Jean Perrin (FR)
- UniCancer Group (FR)
- École Nationale Supérieure des Mines de Paris (FR)
- Institut Curie (FR)
Publication Details
- Journal
- Journal of Clinical Oncology
- Published
- 2025-08-22
- DOI
- https://doi.org/10.1200/jco-25-00742
- Citations
- 5
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 4.68